نتائج البحث - Margo Heath‐Chiozzi

  • يعرض 1 - 7 نتائج من 7
تنقيح النتائج
  1. 1
    The duration of viral suppression during protease inhibitor therapy for HIV-1 infection is predicted by plasma HIV-1 RNA at the nadir

    The duration of viral suppression during protease inhibitor therapy for HIV-1 infection is predicted by plasma HIV-1 RNA at the nadir حسب Dale J. Kempf, Richard A. Rode, Yi Xu, Eugene Sun, Margo Heath‐Chiozzi, Joaquin Valdes, Anthony J. Japour, Sven Danner, Charles A. Boucher, Akhteruzzaman Molla, John M. Leonard

    منشور في 1998
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    Characterization of Viral Dynamics in Human Immunodeficiency Virus Type 1–Infected Patients Treated with Combination Antiretroviral Therapy: Relationships to Host Factors, Cellular Restoration, and Virologic End Points

    Characterization of Viral Dynamics in Human Immunodeficiency Virus Type 1–Infected Patients Treated with Combination Antiretroviral Therapy: Relationships to Host Factors, Cellular... حسب Hulin Wu, Daniel R. Kuritzkes, Daniel McClernon, Harold A. Kessler, Elizabeth Connick, Alan Landay, Greg T. Spear, Margo Heath‐Chiozzi, Franck Rousseau, Lawrence Fox, John Spritzler, John M. Leonard, Michael M. Lederman

    منشور في 1999
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    Response to immunization with recall and neoantigens after prolonged administration of an HIV-1 protease inhibitor-containing regimen

    Response to immunization with recall and neoantigens after prolonged administration of an HIV-1 protease inhibitor-containing regimen حسب Hernán Valdez, Kimberly Y. Smith, Alan Landay, Elizabeth Connick, Daniel R. Kuritzkes, Harold A. Kessler, Lawrence Fox, John Spritzler, Joana D'Arc Roe, Miriam B. Lederman, Howard M. Lederman, Thomas G. Evans, Margo Heath‐Chiozzi, Michael M. Lederman

    منشور في 2000
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    Anti‐KIT monoclonal antibody CDX‐0159 induces profound and durable mast cell suppression in a healthy volunteer study

    Anti‐KIT monoclonal antibody CDX‐0159 induces profound and durable mast cell suppression in a healthy volunteer study حسب Diego Alvarado, Marcus Maurer, Richard Gedrich, Scott B. Seibel, Michael Murphy, Linda Crew, J. Goldstein, Andrea Crocker, Laura Vitale, Pamela A. Morani, Lawrence J. Thomas, Thomas Hawthorne, Tibor Keler, Diane Young, Elizabeth Crowley, Martin Kankam, Margo Heath‐Chiozzi

    منشور في 2022
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    Immune Reconstitution in the First Year of Potent Antiretroviral Therapy and Its Relationship to Virologic Response

    Immune Reconstitution in the First Year of Potent Antiretroviral Therapy and Its Relationship to Virologic Response حسب Elizabeth Connick, Michael M. Lederman, Brian L. Kotzin, John Spritzler, Daniel R. Kuritzkes, Marty St. Clair, Anne Sevin, Lawrence Fox, Margo Heath Chiozzi, John M. Leonard, Franck Rousseau, Joana D'Arc Roe, Ana Martı́nez, Harold A. Kessler, Alan Landay

    منشور في 2000
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  6. 6
    The Effect of Commencing Combination Antiretroviral Therapy Soon after Human Immunodeficiency Virus Type 1 Infection on Viral Replication and Antiviral Immune Responses

    The Effect of Commencing Combination Antiretroviral Therapy Soon after Human Immunodeficiency Virus Type 1 Infection on Viral Replication and Antiviral Immune Responses حسب Martin Markowitz, Mika Vesanen, Klara Tenner‐Racz, Yunzhen Cao, James Μ. Binley, Andrew H. Talal, Arlene Hurley, Xia Ji, M. Rashid Chaudhry, Melody Yaman, Sarah S. Frankel, Margo Heath‐Chiozzi, John M. Leonard, John P. Moore, Paul Rácz, Douglas F. Nixon, David D. Ho

    منشور في 1999
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  7. 7
    Immunologic Responses Associated with 12 Weeks of Combination Antiretroviral Therapy Consisting of Zidovudine, Lamivudine, and Ritonavir: Results of AIDS Clinical Trials Group Protocol 315

    Immunologic Responses Associated with 12 Weeks of Combination Antiretroviral Therapy Consisting of Zidovudine, Lamivudine, and Ritonavir: Results of AIDS Clinical Trials Group Prot... حسب Michael M. Lederman, Elizabeth Connick, Alan Landay, Daniel R. Kuritzkes, John Spritzler, Marty St. Clair, Brian L. Kotzin, L L Fox, Margo Heath Chiozzi, John M. Leonard, Franck Rousseau, Michael S. Wade, Joana D'Arc Roe, A. L. Sánchez Martinez, Harold A. Kessler

    منشور في 1998
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: